Merck Research and Development Expenses 2010-2024 | MRK

Merck research and development expenses for the twelve months ending June 30, 2024 were $20.426B, a 20.74% decline year-over-year.

  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
  • Merck annual research and development expenses for 2021 were $12.245B, a 8.6% decline from 2020.

Merck Research and Development Expenses 2010-2024 | MRK

  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
  • Merck annual research and development expenses for 2021 were $12.245B, a 8.6% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B